The Storm Behind the Silence: Detecting Cerebral Amyloid Angiopathy-Related Inflammation in a Patient with Dementia

Edward C Daingerfield1,2, Vijairam Selvaraj1,2, Kwame Dapaah-Afriyie1,2

  • 1Division of Hospital Medicine, Department of Medicine Miriam Hospital.

PubMed

Insights

Cerebral amyloid angiopathy-related inflammation (CAA-RI) is a rare inflammatory brain condition. Prompt corticosteroid treatment can significantly improve cognitive and behavioral symptoms in affected older adults.

Area of Science:

  • Neurology
  • Neuroinflammation
  • Neuroradiology

Background:

  • Cerebral amyloid angiopathy-related inflammation (CAA-RI) is a treatable inflammatory variant of cerebral amyloid angiopathy.
  • CAA-RI often presents with acute or subacute cognitive or behavioral decline.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
482
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744